Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
Flaig TW, Salzmann-Sullivan M, Su LJ, Zhang Z, Joshi M, Gijón MA, Kim J, Arcaroli JJ, Van Bokhoven A, Lucia MS, La Rosa FG, Schlaepfer IR.
Flaig TW, et al. Among authors: schlaepfer ir.
Oncotarget. 2017 Apr 21;8(34):56051-56065. doi: 10.18632/oncotarget.17359. eCollection 2017 Aug 22.
Oncotarget. 2017.
PMID: 28915573
Free PMC article.